Showing 61-70 of 264 results for "".
A Chatbot is My Newest Employee of the Month!
https://modernaesthetics.com/topics/practice-development/a-chatbot-is-my-newest-employee-of-the-month/35003/Discover how a chatbot can generate leads (and how it differs from a chatbox).Topical Adaptogens
https://modernaesthetics.com/ma-issues-index/july-august-2025/topical-adaptogens-cosmeceutical-dermatologic-skincare/36657/A novel cosmeceutical category in dermatologic skincareMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Valeant Sells Obagi; Aesthetic Trends Around the Globe
https://modernaesthetics.com/series/matv-news/matv-news-valeant-sells-obagi-aesthetic-trends-around-the-globe/33323/Valeant agrees to sell its Obagi Medical Products business, Syneron Candela is now a private company, and Allergan acquired the Reginica Advanced Rejuvenation System line. Also, coverage of the latest trends in aesthetics, according to new statistics from the International Society of Aesthetic PlastMATV News: New Hair Society; Neurotoxin Satisfaction
https://modernaesthetics.com/series/matv-news/matv-news-new-hair-society-neurotoxin-satisfaction/33406/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we cover new research from Allergan that finds the desire to boost self-confidence drives women to seek aesthetic treatments, and there's a new platform that allows potential patients to simulate cosmetic surgical and nonMATV News: VCS Highlights; Volbella XC Approved
https://modernaesthetics.com/series/matv-news/matv-news-vcs-highlights-volbella-xc-approved/33409/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we cover the recent Vegas Cosmetic Surgery meeting as well as the FDA approval of Allergan's Juvéderm Volbella XC for lip augmentation and for correction of perioral rhytids. Also in this episode, Galderma celebrates RestInside AAFPRS
https://modernaesthetics.com/topics/injectables/inside-aafprs/35052/Paradigm Shift: The Science Behind Emsculpt's HIFEM Technology for Reducing Fat and Building Muscle
https://modernaesthetics.com/ma-supplements/2018-july-aug-insert/paradigm-shift-the-science-behind-emsculpts-hifem-technology-for-reducing-fat-and-building-muscle/34101/Muscle hypertrophy plus fat reduction offers optimized outcomes.Coming & Going: July/August 2021
https://modernaesthetics.com/topics/energy-based-devices/coming-going-julyaugust-2021/35068/Coming & Going: November/December 2020
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/coming-going-novemberdecember-2020/34979/